A disciplined, highly targeted approach to discovering new cancer medicines
Rigorous, definitive clinical trials based on deep oncology expertise
Committed to bringing differentiated new cancer medicines to patients
ARIAD's first internally discovered and developed medicine
ARIAD Announces Dismissal of Shareholder Class Action Lawsuit in Federal District Court
ARIAD and Medison Pharma Announce Approval of Iclusig (Ponatinib) in Israel
A shared commitment to patients and each other. This is ARIAD.
click here for PDF